ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

Construction, Senior Biomedical Service Not In Legislation

November 4, 1988

Oncotype DX Cancer Test Can Predict Recurrence

November 25, 2011

Childhood Cancer Survivors May Have Early Heart Problems

July 25, 2003

DCCP Board Oks Fur New Concepts

July 17, 1981

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

NCI Advisory Group, Other Cancer Meetings For April, May

March 26, 1976